Abstract
Introduction: In advanced HCC the overall benefits of multi-kinase inhibitors are limited, but some patients show partial response (PR) and a few achieve complete response (CR). Bio-mathematical modeling of in-vivo cancer cell dynamics by radiomics combining digital imaging and serological biomarkers would provide a better understanding of PR/CR.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
